Tennessee Oncology Chattanooga — Chattanooga, Tennessee

Tennessee Oncology Chattanooga is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Oncology Chattanooga has participated in 9 clinical trials with 3 currently active.

Therapeutic areas: Carcinoma, Pancreatic Ductal, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis.

Sponsors: Sumitomo Pharma America, Inc., Eli Lilly and Company, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology Chattanooga?

Tennessee Oncology Chattanooga has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology Chattanooga conducted?

Tennessee Oncology Chattanooga has 9 clinical trials on record, with 3 currently active. Their work covers Carcinoma, Pancreatic Ductal, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis.

Is Tennessee Oncology Chattanooga accredited by Crixeo Health?

Yes — Tennessee Oncology Chattanooga holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Tennessee Oncology Chattanooga?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.